You have 9 free searches left this month | for more free features.

Lou Gehrig's disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Amyotrophic Lateral Sclerosis, Lou Gehrig Disease, Familial Amyotrophic Lateral Sclerosis Trial in Saint Louis (Rehabilitation)

Enrolling by invitation
  • Amyotrophic Lateral Sclerosis
  • +4 more
  • Rehabilitation
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 10, 2023

Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig Disease Trial in United States (BHV-0223)

Completed
  • Amyotrophic Lateral Sclerosis
  • +5 more
  • Fort Lauderdale, Florida
  • +4 more
Feb 28, 2022

Amyotrophic Lateral Sclerosis, Motor Neuron Disease Trial in New York (noninvasive positive pressure ventilation)

Terminated
  • Amyotrophic Lateral Sclerosis
  • Motor Neuron Disease
  • noninvasive positive pressure ventilation
  • New York, New York
    Eleanor and Lou Gehrig ALS/MDA Center at Columbia University
Nov 5, 2020

Amyotrophic Lateral Sclerosis Trial (89Zr-DFO-AP-101)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Jul 26, 2023

Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig Disease Trial (Riluzole)

No longer available
  • Amyotrophic Lateral Sclerosis
  • +5 more
  • (no location specified)
Jul 24, 2019

Amyotrophic Lateral Sclerosis Trial in Chicago

Recruiting
  • Amyotrophic Lateral Sclerosis
    • Chicago, Illinois
      University of Illinois at Chicago
    Nov 3, 2022

    Amyotrophic Lateral Sclerosis Trial in United States (KNS-760704)

    Completed
    • Amyotrophic Lateral Sclerosis
    • Little Rock, Arkansas
    • +18 more
    Jul 22, 2021

    Amyotrophic Lateral Sclerosis Trial (Pridopidine)

    Available
    • Amyotrophic Lateral Sclerosis
    • (no location specified)
    Sep 27, 2023

    Amyotrophic Lateral Sclerosis Trial in United States (Placebo, Dexpramipexole 50 mg/day, Dexpramipexole 150 mg/day)

    Completed
    • Amyotrophic Lateral Sclerosis
    • Placebo
    • +3 more
    • Little Rock, Arkansas
    • +20 more
    Jun 16, 2021

    Amyotrophic Lateral Sclerosis Trial in Boston (Trehalose)

    Temporarily not available
    • Amyotrophic Lateral Sclerosis
    • Boston, Massachusetts
      Sean M. Healey & AMG Center for ALS Neurological Clinical Resear
    Dec 14, 2022

    Amyotrophic Lateral Sclerosis Trial in Atlanta

    Recruiting
    • Amyotrophic Lateral Sclerosis
      • Atlanta, Georgia
        CDC
      May 11, 2022

      Amyotrophic Lateral Sclerosis Trial (DNL343, Matching Placebo)

      Not yet recruiting
      • Amyotrophic Lateral Sclerosis
      • (no location specified)
      Apr 24, 2023

      Amyotrophic Lateral Sclerosis Trial (ABBV-CLS-7262 Dose 1, ABBV-CLS-7262 Dose 2, Matching Placebo)

      Not yet recruiting
      • Amyotrophic Lateral Sclerosis
      • ABBV-CLS-7262 Dose 1
      • +2 more
      • (no location specified)
      Feb 12, 2023

      Speech Analysis in ALS Patients

      Unknown status
      • ALS
      • +2 more
        • Phoenix, Arizona
          Barrow Neurological Institute
        Mar 6, 2019

        Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy

        Enrolling by invitation
        • Amyotrophic Lateral Sclerosis
        • +9 more
          • Worcester, Massachusetts
            University of Massachusetts Medical School
          May 16, 2022

          Healthy Volunteers, Atopic Diathesis and Atopic Dermatitis Trial in Berlin, Leiden (LOU064, Placebo)

          Completed
          • Healthy Volunteers, Atopic Diathesis and Atopic Dermatitis
          • Berlin, Germany
          • +1 more
          Oct 7, 2021

          Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

          Not yet recruiting
          • Alzheimer Disease
          • +2 more
            • (no location specified)
            Nov 3, 2021

            Amyotrophic Lateral Sclerosis Trial in Boston (Pridopidine, Matching Placebo)

            Active, not recruiting
            • Amyotrophic Lateral Sclerosis
            • Boston, Massachusetts
              Healey Center for ALS at Mass General
            Sep 18, 2022

            Amyotrophic Lateral Sclerosis Trial in Boston (SLS-005, Matching Placebo)

            Enrolling by invitation
            • Amyotrophic Lateral Sclerosis
            • Boston, Massachusetts
              Healey Center for ALS at Mass General
            Mar 22, 2022

            Cognitive Impairment, Mild, Cognitive Dysfunction, Amyloid Plaque Trial in Phoenix, Las Vegas (Lenalidomide 10 mg, Placebo)

            Recruiting
            • Cognitive Impairment, Mild
            • +4 more
            • Lenalidomide 10 mg
            • Placebo
            • Phoenix, Arizona
            • +1 more
            Apr 14, 2022

            Amyotrophic Lateral Sclerosis Trial in Busan, Seoul (Trametinib (0.5 mg), Trametinib (1 mg), Riluzole (100 mg))

            Recruiting
            • Amyotrophic Lateral Sclerosis
            • Trametinib (0.5 mg)
            • +2 more
            • Busan, Korea, Republic of
            • +4 more
            Feb 13, 2022

            Amyotrophic Lateral Sclerosis (ALS) Families Project

            Recruiting
            • ALS
              • New York, New York
                Columbia University
              Oct 20, 2021

              Amyotrophic Lateral Sclerosis Trial in Boston (Matching Placebo, Verdiperstat)

              Active, not recruiting
              • Amyotrophic Lateral Sclerosis
              • Boston, Massachusetts
                Healey Center for ALS at Mass General
              Nov 17, 2021

              Amyotrophic Lateral Sclerosis Trial in Boston (Zilucoplan, Matching Placebo)

              Active, not recruiting
              • Amyotrophic Lateral Sclerosis
              • Boston, Massachusetts
                Healey Center for ALS at Mass General
              Nov 17, 2021